128 related articles for article (PubMed ID: 12048679)
21. Achondroplasia in diverse Jewish and Arab populations in Israel: clinical and molecular characterization.
Falik-Zaccai TC; Shachak E; Abeliovitch D; Lerer I; Shefer R; Carmi R; Ries L; Friedman M; Shohat M; Borochowitz Z
Isr Med Assoc J; 2000 Aug; 2(8):601-4. PubMed ID: 10979354
[TBL] [Abstract][Full Text] [Related]
22. A novel missense mutation Ile538Val in the fibroblast growth factor receptor 3 in hypochondroplasia. Mutations in brief no. 122. Online.
Grigelioniené G; Hagenäs L; Eklöf O; Neumeyer L; Haereid PE; Anvret M
Hum Mutat; 1998; 11(4):333. PubMed ID: 10215410
[TBL] [Abstract][Full Text] [Related]
23. Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection.
Rieger-Christ KM; Mourtzinos A; Lee PJ; Zagha RM; Cain J; Silverman M; Libertino JA; Summerhayes IC
Cancer; 2003 Aug; 98(4):737-44. PubMed ID: 12910517
[TBL] [Abstract][Full Text] [Related]
24. An improved tetra-primer PCR approach for the detection of the FGFR3 G380R mutation responsible for achondroplasia.
Etlik O; Koksal V; Tugba Arican-Baris S; Baris I
Mol Cell Probes; 2008 Apr; 22(2):71-5. PubMed ID: 17683901
[TBL] [Abstract][Full Text] [Related]
25. Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma--case report.
Li Y; Holzgreve W; Page-Christiaens GC; Gille JJ; Hahn S
Prenat Diagn; 2004 Nov; 24(11):896-8. PubMed ID: 15565648
[TBL] [Abstract][Full Text] [Related]
26. FGFR3 gene mutation (Gly380Arg) with achondroplasia and i(21q) Down syndrome: phenotype-genotype correlation.
Chen H; Mu X; Sonoda T; Kim KC; Dailey K; Martinez J; Tuck-Muller C; Wertelecki W
South Med J; 2000 Jun; 93(6):622-4. PubMed ID: 10881785
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the FGFR3 gene in Japanese patients with achondroplasia and hypochondroplasia.
Katsumata N; Mikami S; Nagashima-Miyokawa A; Nimura A; Sato N; Horikawa R; Tanae A; Tanaka T
Endocr J; 2000 Mar; 47 Suppl():S121-4. PubMed ID: 10890199
[TBL] [Abstract][Full Text] [Related]
28. [Gly374Arg mutation in Fgfr3 causes achondroplasia in mice].
Wang JM; Du XL; Li CL; Yin LJ; Chen B; Sun J; Su N; Zhao L; Song RH; Song WW; Chen L; Deng CX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):537-41. PubMed ID: 15583977
[TBL] [Abstract][Full Text] [Related]
29. Achondroplasia in Sweden caused by the G1138A mutation in FGFR3.
Alderborn A; Anvret M; Gustavson KH; Hagenäs L; Wadelius C
Acta Paediatr; 1996 Dec; 85(12):1506-7. PubMed ID: 9001669
[TBL] [Abstract][Full Text] [Related]
30. [Gly380Arg and Asn540Lys mutations of fibroblast growth factor receptor 3 in achondroplasia and hypochndroplasia in the Spanish population].
Ezquieta Zubicaray B; Iguacel AO; Varela Junquera JM; Jariego Fente CM; González Gancedo P; Gracia Bouthelier R
Med Clin (Barc); 1999 Mar; 112(8):290-3. PubMed ID: 10207844
[TBL] [Abstract][Full Text] [Related]
31. Rapid combined genotyping assay for four achondroplasia and hypochondroplasia mutations by real-time PCR with multiple detection probes.
Schrijver I; Lay MJ; Zehnder JL
Genet Test; 2004; 8(2):185-9. PubMed ID: 15345118
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.
Rousseau F; Bonaventure J; Legeai-Mallet L; Pelet A; Rozet JM; Maroteaux P; Le Merrer M; Munnich A
Nature; 1994 Sep; 371(6494):252-4. PubMed ID: 8078586
[TBL] [Abstract][Full Text] [Related]
33. An uncommon G375C substitution in a newborn with achondroplasia.
Addor MC; Gudinchet F; Truttmann A; Schorderet DF
Genet Couns; 2000; 11(2):169-74. PubMed ID: 10893668
[TBL] [Abstract][Full Text] [Related]
34. Novel mutation and RNA splice variant of fibroblast growth factor receptor 3 in multiple myeloma patients at diagnosis.
Soverini S; Terragna C; Testoni N; Ruggeri D; Tosi P; Zamagni E; Cellini C; Cavo M; Baccarani M; Tura S; Martinelli G
Haematologica; 2002 Oct; 87(10):1036-40. PubMed ID: 12368157
[TBL] [Abstract][Full Text] [Related]
35. Achondroplasia is defined by recurrent G380R mutations of FGFR3.
Bellus GA; Hefferon TW; Ortiz de Luna RI; Hecht JT; Horton WA; Machado M; Kaitila I; McIntosh I; Francomano CA
Am J Hum Genet; 1995 Feb; 56(2):368-73. PubMed ID: 7847369
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK.
Koike M; Yamanaka Y; Inoue M; Tanaka H; Nishimura R; Seino Y
J Bone Miner Res; 2003 Nov; 18(11):2043-51. PubMed ID: 14606518
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
38. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.
Webster MK; Donoghue DJ
EMBO J; 1996 Feb; 15(3):520-7. PubMed ID: 8599935
[TBL] [Abstract][Full Text] [Related]
39. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
[TBL] [Abstract][Full Text] [Related]
40. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
Colvin JS; Bohne BA; Harding GW; McEwen DG; Ornitz DM
Nat Genet; 1996 Apr; 12(4):390-7. PubMed ID: 8630492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
